Antibody A13: a new molecule to fight the Alzheimer?
A team of the EBRI is studying A13 antibody, a molecule that promotes the birth of neurons and could be used against Alzheimer's disease.
A team of the EBRI is studying A13 antibody, a molecule that promotes the birth of neurons and could be used against Alzheimer's disease.
TRACE4AD is able to perform an early diagnosis of Alzheimer by exploiting the potential of Artificial Intelligence and Computer Computing.
The Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001
2017 – 2025 The Patent ™ Director Giovanni Sapere
The Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001